article thumbnail

Navigating the rapidly changing oncology treatment landscape: how digital tools can help

Impetus Digital

In 2022, global spending on cancer medicines was approximately 196 billion USD, and this number is forecasted to reach $375 billion by 2027. In turn, these insights can be used as a basis for digital education initiatives for other healthcare providers and patients on the currently available treatment choices and therapies in development.

article thumbnail

How retailers and “payviders” are disrupting U.S. healthcare in 2024

Clarivate

The downsizing is not a total reversal of Walgreens’ aggressive primary-care clinic expansion plan (which in 2021 imagined 1,000 VillageMD clinics by 2027), but rather a reallocation of capital to increase VillageMD’s density in “high-opportunity” markets—i.e., those with high patient volumes.

Retail 52
article thumbnail

U.S. market access landscape: A push for control is erasing the boundary between payers and providers in U.S. healthcare

Clarivate

In 2019, while Walgreens was selling off the last of its healthcare clinics to partnering health systems, CVS announced a transition of its nearly 1,200 MinuteClinics to larger format HealthHUBs focused on chronic disease management and preventive medicine.